Moderna May Supply Up to 160 Million COVID-19 Vaccine Doses to EU

Moderna announced that it has concluded exploratory talks with the European Commission for a deal to supply up to 160 million doses of its COVID-19 vaccine.

The commission is expected to purchase 80 million doses of Moderna’s mRNA-1273 vaccine candidate and has an option to purchase an additional 80 million doses. Swiss manufacturer Lonza and Spain-based ROVI will manufacture the vaccine for Europe.

Moderna began phase 3 testing of vaccine candidate mRNA-1273 in July and is on track to complete enrollment of 30,000 patients in September.